Navigation Links
EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference
Date:2/26/2008

ROCKVILLE, Md., Feb. 26 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that James S. Burns, President and Chief Executive Officer, will present a Corporate overview at the Jesup & Lamont Emerging Growth Stock Conference, which will be held at the Disney Contemporary Resort in Orlando, Florida on Thursday, February 28, 2008. Mr. Burns is scheduled to present at 1:35 p.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO)

Mr. Burns' live presentation will not be web cast, but will be available through the Company's web site at http://www.entremed.com.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. Panzem(R) (2-methoxyestradiol) NCD is also in multiple Phase 2 studies in oncology patients. Additionally, ENMD-1198, a novel anticancer drug, is in Phase 1 studies in advanced cancers. The Company has approved IND applications for Panzem(R) in rheumatoid arthritis, and ENMD-2076, a dual-acting Aurora- angiogenesis inhibitor, for cancer. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoi
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. EntreMed Receives Deloitte Technology Fast 50 Award
2. EntreMed to Present at the Bio 2007 Investor Forum
3. EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
4. EntreMed to Present at the Rodman and Renshaw 9th Annual Healthcare Conference
5. EntreMed Reports Third Quarter 2007 Financial Results
6. EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
7. EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
8. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
9. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
10. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...son of plans finds differences in mood despite sim...lthDay News) -- Both a high-fat, low-carbohydrate ...fat, high-carb diet appear to help people lose pou...od? Only the low-fat diets will result in long-ter... Nov. 9 issue of Archives of Internal Medicine . ...
(Date:11/9/2009)...HENZHEN, China, Nov. 9 /PRNewswire-FirstCall/ - Ha...m , announced today that Novartis, a US$41 billion... 85% stake in HTDS, H1N1 Vaccine partner, Zhejiang... million. Novartis of Switzerland will begin a fiv... the company will dramatically increase its invest...
(Date:11/9/2009)... Course, to be Offered in April ...olkit , Cambridge, MA (Vo...ysicians for Human Rights (PHR) first inspected a ...tan , he realized he would need a team of experts ...ing the site properly was a key first step in secu...
(Date:11/9/2009)...ANTA MONICA, Calif., Nov. 9 Actres...on joined philosophy on Saturday to raise aw...rt services throughout California by building heal.... Enough kits were created to give one to each of... one of Los Angeles County,s domestic violence she...
(Date:11/9/2009)...HICAGO, Nov. 9 Highlighting a comm...ons with advanced entertainment and digital displa... its latest Long-Term Care and Hospital Grade LCD ...rvices for the Aging 2009 annual meeting and expos...h, the new line of "HealthView(TM)" Long-Term Care...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
...n Biosurgical, a global,leader in the custom medic..., CPA has joined the company as Chief Financial Of...irman and Chief Executive Officer and,will have re...or financial management experience, David,will wor...
...ent could help 3.3 million U.S. sufferers, SUNNYV...nounced that 98.4 percent of patients having a pre...ett,s esophagus were free of the disease 2.5,years...g scientific publication for gastrointestinal phys...
...disease puts older men chiefly at risk, study find... The prevalence of mantle cell lymphoma, an aggres...and most patients are diagnosed with advanced stag...urable cancer of the immune system, characterized ...
...re Featured at East LA Meets Napa - a Celebr...on, LOS ANGELES, July 18 AltaMed Health Services...ation featuring more than 20 Latino,owned/managed ...enjoyed great music, food from some of the best,Me...
...ficant health benefits, NEW YORK, July 18 The Re...t and obesity -- today issued a call to action for...ight loss. This action comes,as the result of the ... weight, and that there is no real benefit in,losi...
...ng the wide spectrum of the animal and human world...oral Ecology Congress, hosted by the International...008, at Cornell University in Ithaca., In addition..., Yale University, on "When Theory Meets Data: Wha...
Other Medicine News:Health News:American Biosurgical Adds David Brazeal, CPA as Chief Financial Officer 2Health News:Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System 2Health News:Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System 3Health News:Incidence of Mantle Cell Lymphoma on Rise 2Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 2Health News:Move Over Margarita! Mexican Food has a New Dinner Partner 3Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 3
(Date:11/9/2009)...NATICK, Mass., Nov. 9 Bo...nounced the launch of its COGNIS® cardiac res...ELIGEN® implantable cardioverter defibrillato...the Japanese Ministry of Health, Labor and Welfare...val in September. COGNIS and TELIGEN are the resu...
(Date:11/9/2009)...MIAMI, Nov. 9 ISTA Pharm... additional results from the Company,s Bepreve(TM)...hase 3 clinical studies. These results were prese... of the American College of Allergy, Asthma & ... poster presentation titled, "Treatment of Ocular ...
(Date:11/9/2009)...SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCall/ -...aceutical company focused on developing and commer...treatment of immune mediated diseases and cancer, ...nt, Preclinical Development will provide an overvi...riman Curhan Ford,s 6th Annual Investor Summit. ,...
Breaking Medicine Technology:Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2HealthWell Foundation 28R 29 Appoints New Executive Director 59749 1HealthWell Foundation 28R 29 Appoints New Executive Director 59749 2If Hearing Loss is Not Treated Brain Can Forget How to Hear and Understand Speech 59746 1If Hearing Loss is Not Treated Brain Can Forget How to Hear and Understand Speech 59746 2IPRO Wins Federal Contract to Support Hospice Oversight 59743 1IPRO Wins Federal Contract to Support Hospice Oversight 59743 2
...ticals,Inc. (Amex: IMM ) today announced that it ...tium led by the University of North Carolina at Ch...l & Melinda Gates Foundation,(the "Gates Foundatio...g,sickness (trypanosomiasis) and leishmania. This ...ation has granted to the UNC-led consortium (the,"...
...rom the,Alzheimer,s Foundation of America (AFA) to...ry screenings, especially in light of research,ind...re not recognized,often enough and that early diag...positive interventions. Eric J. Hall, AFA,s chief....D., senior research scientist at the Stanford/VA ...
Other Medicine Technology:Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 4
...kstone Anterior Cervical Plate System provides mor...tive design of our dependable top locking plate pr...ates variable-angle screw placement. Simple, relia...unique universal guidefacilitates procedures and m...
...irTM anterior cervical plate system is the lowest ...ght includes an integrated lock mechanism, which i.... Surgeons appreciate the narrow width, which decr...ired. The system also offers easy to use instrumen...
...h®, Inc. has been providing excellence in Ambu...nds of physicians in the diagnosis and treatment o...each year. State-of-the-art equipment and technolo...ard of customer service makes LifeWatch the provid...
Solo HT Microplate Incubator
Medicine Products: